Causes of death and anticoagulant therapy at time of death in the patients that deceased during follow-up (n = 20)
Cause of death . | N . | VKA . | LDA . | LMWH . | No AC . |
---|---|---|---|---|---|
TE | 10 | 4 | 1 | 1* | 4 |
Definite TE | 4 | 1 | 1 | 0 | 2 |
Arterial TE | 2 | 1 | 1 | 0 | 0 |
Venous TE | 2 | 0 | 0 | 0 | 2 |
Probable TE | 6 | 3 | 0 | 1* | 2 |
Bleeding | 5 | 3 | 0 | 1 | 1 |
Others | 5 | 2† | 2† | 0 | 2 |
Sepsis/infection | 3 | 1† | 2† | 0 | 1 |
Drowning | 1 | 1 | 0 | 0 | 0 |
Dilated cardiomyopathy, not ischemic | 1 | 0 | 0 | 0 | 1 |
Cause of death . | N . | VKA . | LDA . | LMWH . | No AC . |
---|---|---|---|---|---|
TE | 10 | 4 | 1 | 1* | 4 |
Definite TE | 4 | 1 | 1 | 0 | 2 |
Arterial TE | 2 | 1 | 1 | 0 | 0 |
Venous TE | 2 | 0 | 0 | 0 | 2 |
Probable TE | 6 | 3 | 0 | 1* | 2 |
Bleeding | 5 | 3 | 0 | 1 | 1 |
Others | 5 | 2† | 2† | 0 | 2 |
Sepsis/infection | 3 | 1† | 2† | 0 | 1 |
Drowning | 1 | 1 | 0 | 0 | 0 |
Dilated cardiomyopathy, not ischemic | 1 | 0 | 0 | 0 | 1 |